MMEN.CN stock jumped 33.33% to C$0.02 on 03 Feb 2026 during market hours, making MedMen Enterprises Inc. (MMEN.CN) a top gainer on the CNQ exchange in Canada. Volume of 189,038 shares topped the 50-day average and pushed the share price from the intraday low of C$0.015 to the high of C$0.02. Traders cited short-covering and renewed retail interest in low-priced cannabis names. Below we break down the price move, valuation, Meyka AI grade, and a concise outlook for investors watching MMEN.CN stock.
MMEN.CN stock: intraday price action and liquidity
MedMen Enterprises Inc. (MMEN.CN) opened at C$0.015 and traded to a day high of C$0.02, a move of 33.33% on 03 Feb 2026. Volume reached 189,038, above the average volume of 145,639, giving the move higher liquidity. Market cap stands near C$27,664,000.00 with 1,383,200,000 shares outstanding, so even modest flows move the price materially.
MMEN.CN stock: drivers and recent news
The gain appears driven by short-covering and renewed attention to cannabis retailers rather than a fresh earnings beat. There are no new earnings posted since the 2024 announcement, but retail commentary and coverage on platforms pushed trading interest. For company context see MedMen’s site and a recent market summary MedMen and a market update on the move Investing.
Valuation and financial snapshot for MMEN.CN stock
MedMen reports trailing EPS of -0.15 and a negative PE of -0.13, reflecting ongoing losses. Price averages are C$0.02 (50-day C$0.02) and 200-day C$0.03, with a 52-week range C$0.02 to C$0.05. Key ratios show price-to-sales 0.14 and price-to-book 0.11, but the company has a low current ratio 0.49 and debt-to-equity 2.61, highlighting liquidity and leverage stress that affect valuation.
Meyka AI grade and model forecast for MMEN.CN stock
Meyka AI rates MMEN.CN with a score of 56.51 out of 100 — Grade C+, Suggestion: HOLD. This grade factors in S&P 500 benchmark comparison, sector and industry comparison, financial growth, key metrics, forecasts, analyst consensus and fundamental growth. Meyka AI’s forecast model projects a 12-month target of C$0.04, implying an upside of 100.00% from the current C$0.02. Forecasts are model-based projections and not guarantees. These grades are not guaranteed and we are not financial advisors.
Risks and opportunities affecting MMEN.CN stock
Opportunity: a low float and small market cap make MMEN.CN stock sensitive to positive sentiment and short squeezes. Risk: negative operating margins, weak liquidity, and heavy leverage create downside if retail interest fades. Regulatory changes in U.S. cannabis markets, store footprint execution, and access to working capital will determine medium-term outcomes.
Trading outlook and sector context for MMEN.CN stock
Cannabis and specialty drug retail peers remain volatile; healthcare sector averages show stronger margins and higher PE multiples. Short-term traders may target the C$0.02–C$0.05 range with stop-loss discipline. For buy-and-hold investors, the combination of negative cash flow per share -0.06 and low current ratio argues for caution unless material operational improvement appears.
Final Thoughts
MMEN.CN stock’s 33.33% jump to C$0.02 on 03 Feb 2026 was driven by heightened retail flow and above-average volume of 189,038 shares. Valuation metrics remain strained: EPS -0.15, negative PE -0.13, price-to-sales 0.14, and a low current ratio 0.49. Meyka AI’s model projects a 12-month target of C$0.04, an implied upside of 100.00%, but the upside depends on improving cash flow, reduced leverage, and sustained retail interest. Short-term traders can exploit momentum, but longer-term investors should weigh the balance sheet risk and regulatory uncertainty in U.S. cannabis markets. As an AI-powered market analysis platform, Meyka AI flags MMEN.CN as speculative and assigns a C+ / HOLD grade until clearer operational progress appears. Forecasts are model-based projections and not guarantees; manage position size and use risk controls in the CNQ (Canada) market.
FAQs
What caused the MMEN.CN stock surge on 03 Feb 2026?
The surge was mainly retail-driven with short-covering and higher volume. No new earnings were reported; sentiment around cannabis retail names lifted MMEN.CN stock to C$0.02 on above-average volume.
What is Meyka AI’s view and grade for MMEN.CN stock?
Meyka AI rates MMEN.CN at 56.51/100 (C+) with a HOLD suggestion. The grade factors in benchmark comparisons, sector and financial metrics, forecasts, and analyst signals.
What price target does Meyka AI give for MMEN.CN stock?
Meyka AI’s forecast model projects a 12-month target of C$0.04, an implied upside of 100.00% versus the current C$0.02. This is a model projection and not a guarantee.
Should investors trade MMEN.CN stock now?
MMEN.CN stock is speculative. Traders may use short-term momentum strategies with tight stops. Long-term investors should wait for clearer cash-flow improvement, lower leverage, or regulatory clarity before adding exposure.
Disclaimer:
Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.
What brings you to Meyka?
Pick what interests you most and we will get you started.
I'm here to read news
Find more articles like this one
I'm here to research stocks
Ask our AI about any stock
I'm here to track my Portfolio
Get daily updates and alerts (coming March 2026)